---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-289107"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2022-11-18T23:59:59+00:00"
generated_at: "2026-06-21T16:05:14.643641+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks closes $99.1M bought-deal equity offering of 41.4M shares

## Summary
- Bought deal of 41,383,877 shares at $2.4164/share; net proceeds ~$99.1M after expenses.
- Underwriter granted 30-day option to purchase up to 6,207,581 additional shares at same price.
- Proceeds offset $80M cash used for Bayer CropScience asset acquisition and strengthen balance sheet.
- Offering closed on November 18, 2022; underwriter BTIG, LLC.

## SEC filing metadata
- accession: 0001193125-22-289107
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2022-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000119312522289107/0001193125-22-289107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000119312522289107/d411326d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-289107
- JSON: https://secwatch.observer/filing/0001193125-22-289107.json
- Plain text: https://secwatch.observer/filing/0001193125-22-289107.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.